A Stock You Should Be Looking At: MediWound Ltd. (NASDAQ:MDWD)

The price of MediWound Ltd. (NASDAQ: MDWD) closed at $1.65 in the last session, up 5.10% from day before closing price of $1.57. In other words, the price has increased by $+0.0800 from its previous closing price. On the day, 121470 shares were traded. MDWD stock price reached its highest trading level at $1.6700 during the session, while it also had its lowest trading level at $1.5500.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.



We take a closer look at MDWD’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.50 and its Current Ratio is at 2.70. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.59.

Upgrades & Downgrades

On September 23, 2020, BTIG Research started tracking the stock assigning a Buy rating and target price of $6.

On November 28, 2016, Aegis Capital started tracking the stock assigning a Buy rating and target price of $11.Aegis Capital initiated its Buy rating on November 28, 2016, with a $11 target price.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 3.23 while its Price-to-Book (P/B) ratio in mrq is 33.00.

Stock Price History:

Over the past 52 weeks, MDWD has reached a high of $3.38, while it has fallen to a 52-week low of $1.21. The 50-Day Moving Average of the stock is 1.4474, while the 200-Day Moving Average is calculated to be 1.8103.

Shares Statistics:

According to the various share statistics, MDWD traded on average about 136.95K shares per day over the past 3-months and 159.3k shares per day over the past 10 days. A total of 33.48M shares are outstanding, with a floating share count of 27.60M. Insiders hold about 32.26% of the company’s shares, while institutions hold 21.50% stake in the company. Shares short for MDWD as of Oct 13, 2022 were 98.25k with a Short Ratio of 0.05M, compared to 78.03k on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 0.24% and a Short% of Float of 0.35%.

Earnings Estimates

The company has 4 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.1 for the current quarter, with a high estimate of -$0.08 and a low estimate of -$0.11, while EPS last year was -$0.12. The consensus estimate for the next quarter is -$0.08, with high estimates of -$0.07 and low estimates of -$0.09.

Analysts are recommending an EPS of between -$0.42 and -$0.46 for the fiscal current year, implying an average EPS of -$0.45. EPS for the following year is -$0.23, with 4 analysts recommending between -$0.09 and -$0.34.

Revenue Estimates

According to 4 analysts, the current quarter’s revenue is expected to be $4.6M. It ranges from a high estimate of $4.74M to a low estimate of $4.46M. As of the current estimate, MediWound Ltd.’s year-ago sales were $6.37M, an estimated decrease of -27.80% from the year-ago figure. For the next quarter, 4 analysts are estimating revenue of $4.82M, a decrease of -12.20% over than the figure of -$27.80% in the same quarter last year. There is a high estimate of $5.44M for the next quarter, whereas the lowest estimate is $4.24M.

A total of 4 analysts have provided revenue estimates for MDWD’s current fiscal year. The highest revenue estimate was $19.13M, while the lowest revenue estimate was $17.77M, resulting in an average revenue estimate of $18.48M. In the same quarter a year ago, actual revenue was $23.76M, down -22.20% from the average estimate. Based on 4 analysts’ estimates, the company’s revenue will be $27.39M in the next fiscal year. The high estimate is $29.94M and the low estimate is $24.5M. The average revenue growth estimate for next year is up 48.20% from the average revenue estimate for this year.